title: Dermatitis due to epiregulin deficiency and a critical role of epiregulin in immune-related responses of keratinocyte and macrophage.
abstract: Epidermal growth factor (EGF) family members, including epiregulin (EP), play a fundamental role in epithelial tissues; however, their roles in immune responses and the physiological role of EP remain to be elucidated. The skin has a versatile system of immune surveillance. Biologically active IL-1alpha is released to extracellular space upon damage from keratinocytes and is a major player in skin inflammation. Here, we show that EP is expressed not only in keratinocytes but also in tissue-resident macrophages, and that EP-deficient (EP(-/-)) mice develop chronic dermatitis. Wound healing in the skin in EP(-/-) mice was not impaired in vivo, nor was the growth rate of keratinocytes from EP(-/-) mice different from that of WT mice in vitro. Of interest is that in WT keratinocytes, both IL-1alpha and the secreted form of EP induced down-regulation of IL-18 mRNA expression, which overexpression in the epidermis was reported to induce skin inflammation in mice, whereas the down-regulation of IL-18 induced by IL-1alpha was impaired in EP(-/-) keratinocytes. Although bone marrow transfer experiments indicated that EP deficiency in non-bone-marrow-derived cells is essential for the development of dermatitis, production of proinflammatory cytokines by EP(-/-) macrophages in response to Toll-like receptor agonists was much lower, compared with WT macrophages, whose dysfunction in EP(-/-) macrophages was not compensated by the addition of the secreted form of EP. These findings, taken together, suggested that EP plays a critical role in immune/inflammatory-related responses of keratinocytes and macrophages at the barrier from the outside milieu and that the secreted and membrane-bound forms of EP have distinct functions.
authors.affiliation: Department of Pathology, Research Institute, 1-21-1 Toyama, Shinjuku-ku, Tokyo 162-8655, Japan. sshirasawa@ri.imcj.go.jp
authors.forename: Senji
authors.initials: S
authors.lastname: Shirasawa
authors.forename: Shigeru
authors.initials: S
authors.lastname: Sugiyama
authors.forename: Iwai
authors.initials: I
authors.lastname: Baba
authors.forename: Junichi
authors.initials: J
authors.lastname: Inokuchi
authors.forename: Sayaka
authors.initials: S
authors.lastname: Sekine
authors.forename: Keiko
authors.initials: K
authors.lastname: Ogino
authors.forename: Yuki
authors.initials: Y
authors.lastname: Kawamura
authors.forename: Taeko
authors.initials: T
authors.lastname: Dohi
authors.forename: Manabu
authors.initials: M
authors.lastname: Fujimoto
authors.forename: Takehiko
authors.initials: T
authors.lastname: Sasazuki
mesh_terms: D000818:Animals; D001755:Blastocyst / Q000502:physiology; D004247:DNA / Q000235:genetics / Q000302:isolation & purification; D003872:Dermatitis / Q000235:genetics* / Q000276:immunology; D004815:Epidermal Growth Factor / Q000172:deficiency* / Q000235:genetics / Q000276:immunology; D066260:Epiregulin; D005091:Exons / Q000235:genetics; D015698:Genomic Library; D015603:Keratinocytes / Q000276:immunology*; D008264:Macrophages / Q000276:immunology*; D051379:Mice; D018345:Mice, Knockout; D015183:Restriction Mapping; D033581:Stem Cell Transplantation; D014945:Wound Healing / Q000235:genetics
chemical_list: D066260:Epiregulin; C587881:Ereg protein, mouse; D004815:Epidermal Growth Factor; D004247:DNA